4//SEC Filing
MERRIMACK PHARMACEUTICALS INC 4
Accession 0001179110-15-011301
CIK 0001274792operating
Filed
Jul 16, 8:00 PM ET
Accepted
Jul 17, 4:11 PM ET
Size
11.9 KB
Accession
0001179110-15-011301
Insider Transaction Report
Form 4
Sullivan William A.
CFO and Treasurer
Transactions
- Sale
Common Stock
2015-07-15$11.85/sh−15,000$177,750→ 11,000 total - Exercise/Conversion
Stock Option (right to buy)
2015-07-15−4,404→ 12,096 totalExercise: $2.12Exp: 2018-05-05→ Common Stock (4,404 underlying) - Exercise/Conversion
Stock Option (right to buy)
2015-07-15−10,596→ 0 totalExercise: $2.12Exp: 2017-12-04→ Common Stock (10,596 underlying) - Exercise/Conversion
Common Stock
2015-07-15$2.12/sh+10,596$22,464→ 21,596 total - Exercise/Conversion
Common Stock
2015-07-15$2.12/sh+4,404$9,336→ 26,000 total
Footnotes (3)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.71 to $11.93, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- [F3]This option is fully vested.
Documents
Issuer
MERRIMACK PHARMACEUTICALS INC
CIK 0001274792
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001274792
Filing Metadata
- Form type
- 4
- Filed
- Jul 16, 8:00 PM ET
- Accepted
- Jul 17, 4:11 PM ET
- Size
- 11.9 KB